ネクセラファーマの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2024/06/06 | 1,510 | 1,528 | 1,497 | 1,502 | +6 | +0.4% | 558,700 |
| 2024/06/05 | 1,500 | 1,504 | 1,476 | 1,496 | -3 | -0.2% | 605,100 |
| 2024/06/04 | 1,450 | 1,507 | 1,445 | 1,499 | +59 | +4.1% | 834,100 |
| 2024/06/03 | 1,448 | 1,456 | 1,432 | 1,440 | -12 | -0.8% | 568,400 |
| 2024/05/31 | 1,403 | 1,452 | 1,403 | 1,452 | +56 | +4% | 615,700 |
| 2024/05/30 | 1,375 | 1,412 | 1,374 | 1,396 | +3 | +0.2% | 955,200 |
| 2024/05/29 | 1,428 | 1,433 | 1,393 | 1,393 | -41 | -2.9% | 496,800 |
| 2024/05/28 | 1,434 | 1,455 | 1,425 | 1,434 | +5 | +0.3% | 414,800 |
| 2024/05/27 | 1,408 | 1,438 | 1,404 | 1,429 | +15 | +1.1% | 465,000 |
| 2024/05/24 | 1,420 | 1,449 | 1,414 | 1,414 | -26 | -1.8% | 623,300 |
| 2024/05/23 | 1,431 | 1,473 | 1,422 | 1,440 | +29 | +2.1% | 855,300 |
| 2024/05/22 | 1,383 | 1,428 | 1,379 | 1,411 | -2 | -0.1% | 1,001,000 |
| 2024/05/21 | 1,440 | 1,451 | 1,398 | 1,413 | -57 | -3.9% | 1,903,600 |
| 2024/05/20 | 1,460 | 1,514 | 1,459 | 1,470 | +2 | +0.1% | 961,500 |
| 2024/05/17 | 1,514 | 1,514 | 1,468 | 1,468 | -52 | -3.4% | 1,096,400 |
| 2024/05/16 | 1,515 | 1,537 | 1,514 | 1,520 | +19 | +1.3% | 540,000 |
| 2024/05/15 | 1,567 | 1,594 | 1,501 | 1,501 | -61 | -3.9% | 959,700 |
| 2024/05/14 | 1,520 | 1,570 | 1,513 | 1,562 | +52 | +3.4% | 727,800 |
| 2024/05/13 | 1,490 | 1,532 | 1,485 | 1,510 | +14 | +0.9% | 652,700 |
| 2024/05/10 | 1,489 | 1,579 | 1,475 | 1,496 | -55 | -3.5% | 1,397,400 |
| 2024/05/09 | 1,540 | 1,565 | 1,528 | 1,551 | +5 | +0.3% | 663,000 |
| 2024/05/08 | 1,520 | 1,567 | 1,510 | 1,546 | +22 | +1.4% | 795,700 |
| 2024/05/07 | 1,516 | 1,540 | 1,496 | 1,524 | +5 | +0.3% | 913,100 |
| 2024/05/02 | 1,497 | 1,528 | 1,476 | 1,519 | +25 | +1.7% | 644,100 |
| 2024/05/01 | 1,466 | 1,526 | 1,458 | 1,494 | +26 | +1.8% | 831,100 |
| 2024/04/30 | 1,485 | 1,487 | 1,452 | 1,468 | +10 | +0.7% | 772,100 |
| 2024/04/26 | 1,503 | 1,505 | 1,453 | 1,458 | -37 | -2.5% | 3,093,200 |
| 2024/04/25 | 1,496 | 1,534 | 1,493 | 1,495 | -13 | -0.9% | 731,300 |
| 2024/04/24 | 1,488 | 1,519 | 1,481 | 1,508 | +28 | +1.9% | 708,600 |
| 2024/04/23 | 1,477 | 1,489 | 1,463 | 1,480 | +13 | +0.9% | 584,900 |
| 2024/04/22 | 1,466 | 1,482 | 1,457 | 1,467 | +17 | +1.2% | 602,200 |
| 2024/04/19 | 1,499 | 1,505 | 1,448 | 1,450 | -61 | -4% | 1,064,700 |
| 2024/04/18 | 1,480 | 1,529 | 1,474 | 1,511 | +48 | +3.3% | 762,900 |
| 2024/04/17 | 1,516 | 1,552 | 1,463 | 1,463 | +7 | +0.5% | 1,376,800 |
| 2024/04/16 | 1,485 | 1,492 | 1,451 | 1,456 | -57 | -3.8% | 891,700 |
| 2024/04/15 | 1,488 | 1,529 | 1,470 | 1,513 | +13 | +0.9% | 950,200 |
| 2024/04/12 | 1,530 | 1,537 | 1,463 | 1,500 | -60 | -3.8% | 1,773,000 |
| 2024/04/11 | 1,571 | 1,595 | 1,554 | 1,560 | -31 | -1.9% | 899,800 |
| 2024/04/10 | 1,608 | 1,620 | 1,571 | 1,591 | -31 | -1.9% | 772,800 |
| 2024/04/09 | 1,627 | 1,642 | 1,599 | 1,622 | +73 | +4.7% | 1,736,500 |
| 2024/04/08 | 1,544 | 1,567 | 1,531 | 1,549 | +15 | +1% | 759,100 |
| 2024/04/05 | 1,530 | 1,541 | 1,483 | 1,534 | -36 | -2.3% | 1,245,800 |
| 2024/04/04 | 1,550 | 1,583 | 1,538 | 1,570 | +26 | +1.7% | 720,300 |
| 2024/04/03 | 1,543 | 1,558 | 1,503 | 1,544 | -13 | -0.8% | 1,046,700 |
| 2024/04/02 | 1,614 | 1,616 | 1,547 | 1,557 | -81 | -4.9% | 1,057,000 |
| 2024/04/01 | 1,660 | 1,667 | 1,610 | 1,638 | -24 | -1.4% | 824,600 |
| 2024/03/29 | 1,626 | 1,670 | 1,626 | 1,662 | +41 | +2.5% | 950,200 |
| 2024/03/28 | 1,627 | 1,652 | 1,603 | 1,621 | +19 | +1.2% | 990,700 |
| 2024/03/27 | 1,618 | 1,627 | 1,578 | 1,602 | -12 | -0.7% | 1,054,800 |
| 2024/03/26 | 1,574 | 1,637 | 1,563 | 1,614 | +36 | +2.3% | 1,128,900 |
251～
300
件表示中 / 5111件
類似銘柄と比較する
現在ご覧いただいている「ネクセラファーマ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| ネクセラファーマ | 92,000円 | +20.3% | - | 0.00% | 163.12倍 | 1.22倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
| 杏林製薬 | 148,400円 | -2.4% | -52.3% | 3.84% | 17.76倍 | 0.63倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
| 栄研化 | 220,000円 | +4.1% | -3.1% | 2.64% | 19.16倍 | 1.67倍 |
|
臨床検査薬大手。便潜血検査試薬（ＦＩＴ）はシェア７割。尿検査（ウロ）、遺伝子検査も育成 |
| ＪＣＲファーマ | 55,400円 | +14.3% | - | 3.61% | 22.50倍 | 1.44倍 |
|
ヒト成長ホルモン製剤が主力、バイオ後続品も成長。希少疾病のバイオ新薬開発にも取り組む |
| あすかＨＤ | 233,000円 | +16.9% | +33.2% | 2.36% | 12.71倍 | 1.01倍 |
|
武田と親密。婦人科領域に強い。先発品比率引き上げに注力。２１年春にあすか製薬が持株会社化 |
市場注目の銘柄
チャート関連のコラム
